MétaCan
Menu
← Back to cohort
Record W4210665241 · doi:10.1038/s41586-022-04474-x

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

2022· article· en· W4210665241 on OpenAlexfundno aff
Bo Meng, Adam Abdullahi, Isabella A.T.M. Ferreira, Niluka Goonawardane, Akatsuki Saito, Izumi Kimura, Daichi Yamasoba, Pehuén Pereyra Gerber, Saman Fatihi, Surabhi Rathore, Samantha K. Zepeda, Guido Papa, Steven A. Kemp, Terumasa Ikeda, Mako Toyoda, Toong Seng Tan, Jin Kuramochi, Shigeki Mitsunaga, Takamasa Ueno, Kotaro Shirakawa, Akifumi Takaori‐Kondo, Teresa Brevini, Donna L. Mallery, Oscar Charles, Stephen Baker, Gordon Dougan, Christoph Hess, Nathalie Kingston, Paul J. Lehner, Paul Lyons, Nicholas J. Matheson, Willem H. Ouwehand, Caroline Saunders, Charlotte Summers, James Thaventhiran, Mark Toshner, Michael P. Weekes, Patrick H. Maxwell, Ashley Shaw, Ashlea Bucke, Jo Calder, Laura Canna, Jason Domingo, Anne Elmer, Stewart Fuller, Julie Harris, Sarah Hewitt, Jane Kennet, Sherly Jose, Jenny Kourampa, Anne Meadows, Criona O’Brien, Jane Price, Cherry Publico, Rebecca Rastall, Carla M. S. Ribeiro, Jane Rowlands, Valentina Ruffolo, Hugo Tordesillas, Ben Bullman, Benjamin J. Dunmore, Stefan Ting Graf, Josh Hodgson, Christopher Huang, Kelvin Hunter, Emma Jones, Ekaterina Legchenko, Cecilia Matara, Jennifer Martin, Federica Mescia, Ciara O’Donnell, Linda Pointon, Joy Shih, Rachel Sutcliffe, Tobias Tilly, Carmen Treacy, Zhen Tong, Jennifer Wood, Marta Wylot, Ariana Betancourt, Georgie Bower, Chiara Cossetti, Aloka De, Madeline Epping, Stuart Fawke, Nick Gleadall, Richard Grenfell, Andrew Hinch, Sarah Jackson, Isobel Jarvis, Benjamin A. Krishna, Francesca Nice, Ommar Omarjee, Marianne Perera, Martin Potts, Nathan Richoz, Veronika Romashova, Luca Stefanucci, Mateusz Strezlecki, Lori Turner, Eckart M. D. D. De Bie, Katherine Bunclark, Maša Josipović, Michael Mackay, Helen Butcher, Daniela Caputo, Matt Chandler, Patrick F. Chinnery, Debbie Clapham-Riley, Eleanor Dewhurst, Christian Fernandez, Anita Furlong, Barbara Graves, Jennifer Gray, Sabine Hein, Tasmin Ivers, Emma Le Gresley, Rachel Linger, Mary Kasanicki, Rebecca L. King, Sarah Meloy, Alexei Moulton, Francesca Muldoon, Nigel Ovington, Sofia Papadia, Christopher J. Penkett, Isabel Phelan, Venkatesh-Prasad Ranganath, Roxana Paraschiv, Abigail Sage, Jennifer Sambrook, Ingrid Scholtes, Katherine Schon, Hannah Stark, Kathleen Stirrups, Paul Townsend, Neil Walker, Jennifer Webster, Erika P. Butlertanaka, Yuri Tanaka, Jumpei Ito, Keiya Uriu, Yusuke Kosugi, Mai Suganami, Akiko Oide, Miyabishara Yokoyama, Mika Chiba, Chihiro Motozono, Hesham Nasser, Ryo Shimizu, Kazuko Kitazato, Haruyo Hasebe, Takashi Irie, So Nakagawa, Jiaqi Wu, Miyoko Takahashi, Takasuke Fukuhara, Kenta Shimizu, Kana Tsushima, Haruko Kubo, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Kayoko Nagata, Yugo Kawai, Yohei Yanagida, Yusuke Tashiro, Kenzo Tokunaga, Seiya Ozono, Ryoko Kawabata, Nanami Morizako, Kenji Sadamasu, Hiroyuki Asakura, Mami Nagashima, Kazuhisa Yoshimura, Paúl Cárdenas, Érika Muñoz, Verónica Barragán, Sully Márquez, Belén Prado-Vivar, Mónica Becerra-Wong, Mateo Caravajal, Gabriel Trueba, Patricio Rojas‐Silva, Michelle Grunauer, Bernardo Gutiérrez, Juan José Guadalupe, Juan Carlos Fernández‐Cadena, Derly Andrade-Molina, Manuel E. Baldeón, Andrea Pinos, John E. Bowen, Anshu Joshi, Alexandra C. Walls, Laurelle Jackson, Darren P. Martin, Kenneth G. C. Smith, John R. Bradley, John A. G. Briggs, Jinwook Choi, Elo Madissoon, Kerstin B. Meyer, Petra Mlčochová, Lourdes Ceron‐Gutierrez, Rainer Döffinger, Sarah A. Teichmann, Andrew J. Fisher, Matteo Samuele Pizzuto, Anna De Marco, Davide Corti, Myra Hosmillo, Leo C. James, Lipi Thukral, David Veesler, Alex Sigal, Fotios Sampaziotis, Ian Goodfellow, Kei Sato, Ravindra K. Gupta

Bibliographic record

VenueNature · 2022
Typearticle
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsnot available
FundersStrategic International Collaborative Research ProgramCore Research for Evolutional Science and TechnologyInstitute of GeneticsNational Institute of Allergy and Infectious DiseasesResearch Institute for Microbial Diseases, Osaka UniversityJapan Society for the Promotion of ScienceSouth African Medical Research CouncilNational Institutes of HealthRosetrees TrustNIHR BioResourceUniversity of CambridgeAcademy of Medical SciencesMedical Research CouncilDepartment of Health and Social CareNHS Blood and TransplantNational Institute for Health and Care ResearchFast GrantsEngineering and Physical Sciences Research CouncilUK Research and InnovationTokyo Biochemical Research FoundationWellcome TrustEuropean Association for the Study of the LiverNational Institute of General Medical SciencesBurroughs Wellcome FundHoward Hughes Medical InstituteMitsubishi FoundationTakeda Science FoundationNewcastle UniversityJapan Agency for Medical Research and DevelopmentBill and Melinda Gates Foundation
KeywordsVirologyInfectivityVirusViral entryBiologyChemistryViral replicationMolecular biology

Abstract

fetched live from OpenAlex

The SARS-CoV-2 Omicron BA.1 variant emerged in late 2021 and is characterised by multiple spike mutations across all spike domains. Here we show that Omicron BA.1 has higher affinity for ACE2 compared to Delta, and confers very significant evasion of therapeutic monoclonal and vaccine-elicited polyclonal neutralising antibodies after two doses. mRNA vaccination as a third vaccine dose rescues and broadens neutralisation. Importantly, antiviral drugs remdesevir and molnupiravir retain efficacy against Omicron BA.1. We found that in human nasal epithelial 3D cultures replication was similar for both Omicron and Delta. However, in lower airway organoids, Calu-3 lung cells and gut adenocarcinoma cell lines live Omicron virus demonstrated significantly lower replication in comparison to Delta. We noted that despite presence of mutations predicted to favour spike S1/S2 cleavage, the spike protein is less efficiently cleaved in live Omicron virions compared to Delta virions. We mapped the replication differences between the variants to entry efficiency using spike pseudotyped virus (PV) entry assays. The defect for Omicron PV in specific cell types correlated with higher cellular RNA expression of TMPRSS2, and accordingly knock down of TMPRSS2 impacted Delta entry to a greater extent as compared to Omicron. Furthermore, drug inhibitors targeting specific entry pathways demonstrated that the Omicron spike inefficiently utilises the cellular protease TMPRSS2 that mediates cell entry via plasma membrane fusion. Instead, we demonstrate that Omicron spike has greater dependency on cell entry via the endocytic pathway requiring the activity of endosomal cathepsins to cleave spike. Consistent with suboptimal S1/S2 cleavage and inability to utilise TMPRSS2, syncytium formation by the Omicron spike was dramatically impaired compared to the Delta spike. Overall, Omicron appears to have gained significant evasion from neutralising antibodies whilst maintaining sensitivity to antiviral drugs targeting the polymerase. Omicron has shifted cellular tropism away from TMPRSS2 expressing cells that are enriched in cells found in the lower respiratory and GI tracts, with implications for altered pathogenesis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.349
Teacher spread0.326 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1,167
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueNature→Same topicSARS-CoV-2 and COVID-19 Research→French-language works237,207→